# Ernexa Therapeutics Inc.: Form SC 13D/A, filed Jan 9, 2019

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SC 13D/A
- Filed: 2019-01-09
- Accepted by EDGAR: Jan 9, 2019, 13:47 ET
- Period: not reported
- Accession: 0001062993-19-000106
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000106299319000106/schedule13da_ntn.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000106299319000106/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000106299319000106/schedule13da_ntn.htm

Filed Jan 9, 2019.
Source: SEC EDGAR, the filing index for accession 0001062993-19-000106. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.